UC Berkeley researchers find new potential treatment for obesity and diabetes
Over the past five years, medications called GLP-1s have revolutionized the treatment of metabolic disorders like obesity, diabetes…
World’s largest single-site study maps brain changes under psilocybin
A landmark five-year study by Monash University has found psychedelics reorganise brain patterns, giving clinicians powerful new insights…
Rice University chemists develop cheaper way to synthesize drugs
Pharmaceutical drugs often rely on chemical compounds found in the body. Take phosphate, a common compound cells use…
Targeting CMPK2-intervened redox metabolism to mitigate hepatic ischemia-reperfusion injury
HIRI is a major clinical challenge that occurs when blood supply to the liver is temporarily interrupted and…
New drug candidate treats severe fatty liver disease by improving gut health
Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving gut health,…
New pair of techniques can speed up the search for better tuberculosis drugs
Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb) is the world’s deadliest single-agent caused infection, responsible for 1.23…
Cannabidiol shows preclinical promise for anxiety, depression and cognition
A new Molecular Psychiatry meta-analysis suggests CBD may improve emotional behavior and cognition in animal models, but researchers…
Smart nanoplatform uses wound acidity to trigger accelerated healing
Infected wounds pose a significant medical challenge, often leading to delayed healing and complications due to bacterial biofilms…
This plant extract can make a lethal drug cocktail. Can it also treat opioid addiction?
A plant extract that’s gaining popularity as a pain cure-all and has been associated with multiple California deaths…
Lab trials prove copper therapy enhances cognitive function and spatial learning
Monash University researchers have found in laboratory experiments that a drug which delivers copper to the brain significantly…
Study identifies new therapeutic candidate for KRAS-driven pancreatic cancer
A new research paper was published in Volume 17 of Oncotarget on June 3, 2026, titled “The anticancer effects of PCAIs…
Researchers develop compound 10 to slow Alzheimer’s disease progression
Researchers from ETH Zurich have developed an active ingredient that slows down the progression of typical Alzheimer’s symptoms…